Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 9Cholangiocarcinoma 8Pancreatic Neoplasms 7Gallbladder Neoplasms 6Ovarian Neoplasms 4Esophageal Neoplasms 4Colorectal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Sarcoma 2Rectal Neoplasms 2Neoplasm Metastasis 2Liver Neoplasms 2Klatskin Tumor 2Carcinoma, Hepatocellular 2Anus Neoplasms 2Uterine Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Rhabdomyosarcoma 1Resectable Intrahepatic Cholangiocarcinoma 1Recurrence 1Prostatic Neoplasms 1Peritoneal Neoplasms 1Pelvic Neoplasms 1PRETEXT I Hepatoblastoma 1Mesothelioma, Malignant 1Liposarcoma 1Hepatoblastoma 1Gastrointestinal Neoplasms 1Gastric Adenocarcinoma 1Fibrolamellar hepatocellular carcinoma 1

Interventions

temsirolimus 1dehydroftorafur 1Vincristine 1Sirolimus 1Razoxane 1Platinum 1Liver Transplantation 1Irinotecan 1Fluorouracil 1Doxorubicin 1Dexrazoxane 1Cisplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
PRETEXT I Hepatoblastoma × Platinum × Gastrointestinal × Clear all
NCT00980460 2026-05-04

Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer

National Cancer Institute (NCI)

Phase 3 Active not recruiting
236 enrolled 18 charts
Gastrointestinal

PRETEXT I Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡